Parkinson's Clinical Trial Companion Accelerating Clinical Trials | Page 18

CA SE STUDY NO. 3 Continued from page 15 Results S4 was able to recruit its full target population in a timely manner: 82 individuals were recruited to participate in S4 [Table 2] within 21 months. Although recruitment for the trial took three months longer than originally projected, the S4 Steering Committee considered this to be successful, particularly considering the harder-to-reach target population and complex protocol. Conclusion While a comprehensive site selection process may require a significant investment of time and resources at the outset, the benefits may outweigh the long-term risks (e.g., study delays, additional financial resources, high attrition rates, inability to meet enrollment goals). 8 Developing a checklist such as the one used by the S4 Steering Committee can facilitate the site selection process and lead to more open lines of communication between study sponsors and sites. Sites have an opportunity to share their interest, background and experience, and sponsors can dig deeper into questions they may have about the ways in which the protocol and operating objectives align. 9 Chapter 2 Key Takeaways + + Involve sites as stakeholders early in the study design process to help identify potential challenges and opportunities as they pertain to study feasibility and patient acceptability. + + Use insights provided by sites and other stakeholders to identify and prioritize site characteristics. + + Develop a template or questionnaire to facilitate site assessment and selection process. 8 9 16 Harper, Beth and David Zuckerman. “Critical Success Factors for Planning for Planning for Site Selection and Patient Recruitment Planning.” BioExecutive International (2006) pg.16 Harper and Zuckerman, pg. 17 Accelerating Clinical Trials: Best Practices for Recruitment and Retention